Try our Advanced Search for more refined results
Life Sciences - September, 2010
193 articles
- Merck Balks At $4.6M Verdict In Mass. Medicaid Case
- Novartis Contact Lens Patent Invalid, UK Court Affirms
- ELA Tries To Nix FCA Suit Over Defibrillators
- Chem Rx Creditors Want Exclusivity Extension Blocked
- 2nd Circ. Throws Out DHB Shareholder Settlement
- Novartis Settles Criminal, Qui Tam Cases For $422.5M
- Investor Suit Over Savient Gout Drug Reactions Fails
- Ex-Takeda Sales Rep Files OT Collective Action
- Anchen Sues Labopharm In Bid To Sell Generic Ryzolt
- J&J CEO Offers Mea Culpa Over Stealth Buybacks
- US Joins Patent Pool To Promote Generic HIV Drugs
- Health Care Staffing Firm MSN Exits Ch. 11
- Bristol-Myers To Pay Pa. $27M Over Drug Pricing
- KV Trade Secrets Suit Against Spanish Co. Tossed
- Skadden Reps Danaher In $340M Deal For Keithley
- Bayer Suit Over Generic Yasmin Gets The Boot
- FDA Rule Aims To Improve Reporting For Drug Trials
- Patent Damages Post Festo
- 9th Circ. Snubs Abbott's Challenge To Norvir Cases
- Skadden Advises Endo On $1.2B Qualitest Purchase
- FDA Chides Mouth Rinse Makers For Gum Health Claims
- ITC Denies Bid To Invalidate Toshiba Laptop Patents
- Supreme Court Will Hear Drug Pricing Dispute
- Boston Sci Accuses 9 Cos. Of Infringing Patents
- Plaintiffs Firm Wins Coverage For Fen-Phen Suits
- Indonesian Antitrust Regulator Fines Pfizer Units $14M
- Sanofi Taxotere Patents Ruled Invalid In Hospira Spat
- Novozymes Loses Bid For Ethanol Enzyme Injunction
- Botox Settlement Adds More Frown Lines To Industry
- SEC Goes After Theradoc Exec For Improper Transfers
- Supreme Court To Hear Baycol Class Cert. Dispute
- Immunex, Amgen Fight Back In AWP Spat
- A 'Curious Case' Revisited
- Whistleblower Suits Over Children's Drugs Tossed
- GSK Drug Partner XenoPort Hit With Stock Drop Action
- Novo Nordisk To Challenge Russian Competition Fine
- Guidant Seeks KO Of $700M Heart Device Fraud Suit
- Amgen Recalls Anemia Drugs Due To Glass Flakes
- Abbott Hit With Class Action Over Bugs In Baby Formula
- Russian Watchdog Says Novo Broke Competition Law
- Calif. Reps Call For Probe Of Biovail-Valeant Deal
- Vicks Inhaler Maker Slapped With Patent Marking Suit
- Bristol-Myers Sues Teva To Block Generic Baraclude
- Novartis Sues FDA For OK'ing Generic Herpes Drug
- CVS Workers' OT Class Action Slimmed
- Two Tracks, One Train? CMS And FDA Cooperation
- US, EU Regulators Ban GSK's Avandia In Most Cases
- CBP Nixes Tariffs On Digital Cables, Alzheimer's Drug
- St. Jude Qui Tam Cases Spawn Derivative Suit
- GSK, Roche Spar Over Herceptin Patents
- ACLU Suit Threatens Whistleblower Secrecy
- Shareholders Sue Arena Over Weight Drug Cancer Risk
- Abbott Yanks Baby Formula Over Beetle Contamination
- FDA Warns Irisys Over Production Process Issues
- Stryker Tries To Limit Bone Device Marketing Charges
- J&J Faces Shareholder Action Over Drug Woes
- St. Jude Insurer Remains On Hook For Silzone Claims
- Ranbaxy Gets Dibs On Generic Alzheimer's Drug
- Cypress Investors Resist $163M Ramius Takeover Bid
- Schering Sues Par, Perrigo To Block Generic Zegerid
- Omnicare Ends Medicaid False Claims Suit For $21M
- DOJ Asks To Join Wyeth Rapamune Qui Tam Suit
- Teva Goes After Mylan Over Copaxone Patents
- FDA Denies Greenlighting J&J 'Phantom' Recall
- High Court IP Roundup — Last Session, And What's Next
- China Tops List Of FCPA Hot Spots
- Mylan Wins Bid To Block Apotex's Generic Paxil
- Valeant, Biovail Settle Class Action Over $3B Merger
- Senate GOP Vows To Blockade Pay-For-Delay Ban
- House Proposal Would Give FDA Drug-Recall Power
- Q&A With Skadden's David Zornow
- Genzyme Defeats 1 Of 3 Defenses In Hectorol IP Suit
- Boston Sci Buys Asthma Treatment Maker For $443M
- The Muddy Collaboration Element Of Joint Inventorship
- J&J Plans €1.75B Offer For Dutch Vaccine Developer
- US Seeks Quick Win In $15M Navy Drug Testing Spat
- Case Study: Sonoran Scanners V. PerkinElmer
- Watson Wants Nev. Fentanyl Death Suit In Fed. Court
- Amgen Kickback Suits Consolidated On Appeal
- Breckenridge Still On The Hook In Trade Dress Suit
- Taro, Shire Strike Deal Over Generic Epilepsy Drug
- Jurisdictional Discovery OK'd In OxyContin IP Suit
- ConMed Targets Ex-Employee In Trade Secrets Suit
- Generics Subject To Solvay Sham Litigation Claims
- Medical Marijuana And The Workplace
- Bristol-Myers, ZymoGenetics Hit With Suit Over Merger
- White House Lays Out Plan To Double U.S. Exports
- Slaine To Pay Nearly $1M To End UBS Trading Probe
- FDA's 510(k) Device Approval Process Effective: Study
- Novartis MDL Plaintiffs Seek To Lift Protective Order
- Novartis Must Reply To Wyeth's Bid To Move IP Suit
- 8th Circ. Kills Suit Over Medtronic's Fidelis Disclosures
- Apotex, Wyeth Settle Suit Over Generic Effexor
- AbTox Execs Seek New Trial Over Witness 'Perjury'
- WestMed Issues Class I Recall Of Resuscitators
- Ark. Intervenes In Wyeth Protonix Qui Tam Suits
- Wyeth Asks 6th Circ. To Rehear Preemption Case
- Forest Agrees To Drop $313M To Settle Qui Tam Claims
- FDA Panel Splits On Banning Abbott's Meridia
- 9th Circ. Limits Electronic Search In MLB Steroid Case
- MoFo Picks Up M&A Adviser From Holme Roberts
- Wolf Greenfield Beats Malpractice Rap In RNA IP Suit
- Acura Accused Of Securities Fraud Over Acurox
- Pfizer Off The Hook In Genotropin Kickback Suit
- Ramius Boosts Cypress Bid To $163M
- Eastern District Of Texas — Plaintiffs' Paradise Lost?
- GSK Gets Patent Cut From Wellbutrin Antitrust Action
- The Curious Case Of Pharma Sales Reps And The FLSA
- Task Force Links Biphosphonates To Rare Bone Breaks
- SAG Settles With Actors Over Foreign Royalties
- Astellas Hit With Antitrust Suit Over Stress Test System
- FDA Blasts Bristol-Myers Over Puerto Rico Plant
- Sanofi Wins Appeal, Stay In Lovenox Antitrust Suit
- Harvard Prof's Proxy Access Case Against EA Revived
- AstraZeneca Sues Osmotic Over Seroquel ANDA
- Acura Hit With Securities Suit Over Acurox Claims
- LabCorp To Acquire Genzyme Unit For $925M
- Abbott Wins 'Sorvir' Trademark Dispute In EU Court
- 7th Circ. Revives Bemis Retirees' ERISA Class Action
- Most Admired Attys: Wheeler Trigg's Malcolm Wheeler
- FDA Mulls Pulling Abbott Diet Drug
- Fed. Circ. Revives Patent Row Over Prostate Laser
- GAO OKs VA's Rejection Of Medtronic Contract
- Bayer Wins Toss Of Expert Testimony In Trasylol MDL
- Q&A With McDermott's Sarah Chapin Columbia
- 3rd-Party Payor Class Nixed In Lilly Zyprexa Appeal
- Fed. Circ. Trims $7.4M Award In Medtronic Patent Suit
- Goldman M&A Expert To Be New GSK CFO
- Most Admired Attys: Alston & Bird's Jane Thorpe
- Medtronic Whistleblower's Kickback Suit Tossed
- Mylan Loses Bid To Toss Daiichi Benicar Patent
- Abbott Hits Teva With Another Suit Over Generic Simcor
- 4-Year Sentence Handed Down In Medicare Fraud Case
- FDA Warns E-Cigarette Cos. Over Unapproved Products
- FDA Toughens Warnings On MRI Contrast Agents
- Most Admired Attys: Dechert's Diane Sullivan
- Lundbeck Dodges FTC Suit Over Heart Drugs
- Genzyme Shareholder Sues Over Sanofi Bid Rejection
- Indirect Buyers' Wellbutrin Antitrust Suit Lives On
- Allergan Sues Apotex Over Latisse ANDA
- MOFCOM's Stance On Novartis/Alcon
- Jury Awards Blinded Woman $21M Over Sulindac
- FDA Warns Unilever Over Green Tea Health Claims
- Fosamax Judge Weighs Tossing Of $8M Boles Verdict
- Sandoz Can't Escape Teva's Copaxone Patent Suit
- Judge Finds Pfizer Manipulated Subsidiary's Ch. 11
- Most Admired Attys: Sills Cummis' Beth Rose
- SciClone Hit With Shareholder Suit Amid DOJ, SEC Probe
- Purdue To Pay $16M To Settle OxyContin Claims
- Merck, J&J Head To Arbitration Over Remicade Deal
- Immucor, Ortho-Clinical Want Dismissal Bid Reheard
- The 25% Rule Lives On
- 2nd Circ. Won't Rehear Cipro Pay-For-Delay Suit
- Most Admired Attys: Faegre & Benson's Joe Price
- 3 IP Groups Are Tops For In-House Counsel
- Sales Rep Hits Astellas With Overtime Action
- Most Admired Attys: Reed Smith's Kurt Gwynne
- Radio Flyer Sued For Using Expired Patent
- Pharmacists Welcome Medicaid AMP Rule Revisions
- Allergan Board Must Pay For $600M DOJ Deal, Suit Says
- Claims Against J&J In 8 States Dismissed In AWP MDL
- Eli Lilly V. Gottstein: In Defense Of Protective Orders
- P&G Wins Dismissal Of Vicks Vitamin C Class Action
- Most Admired Attys: Shook Hardy's Harvey Kaplan
- Novartis MDL Plaintiffs Told Not To 'Abuse' Sealed Docs
- Judge Removes Block On Watson's Generic Yasmin
- The 4 Firms In-House Counsel Fear The Most
- Roche, Ranbaxy Settlement Ends Valcyte Patent Battle
- Allergan Hits Watson With Patent Suit Over Combigan
- Judge Shuts Down Actimmune Marketing MDL
- FDA Warns Of Mortality Risks From Wyeth Antibiotic
- LabCorp Sues Cardinal Over $74M Lab Sale Pact
- SEC Settles Insider Trading Suit Over Pharma Deal
- Most Admired Attys: MoFo's James Huston
- Grant & Eisenhofer Scores Nussbaum Antitrust Crew
- ITC Initiates Probe Over Invacare Medical Bed Patents
- J&J, Target, CVS Escape Toxic Bath Products Action
- Bayer Unit Sues Generics Maker Over Acne Treatment
- Columbia Tries To Cap Coverage For Ambient Syringes
- Study Says Meridia May Up Risk Of Heart Attack, Stroke
- USPTO Rolls Out New Obviousness Rules
- Fed. Circ. Upholds Ban On Teva's Generic Evista
- Pa. Appeals Court Revives 14 Prempro Suits
- GSK Fails Again To Nix Antitrust Claims Over Wellbutrin
- Sanofi, WC Heraeus Drop Patent Spat Over Eloxatin
- Dr. Reddy's Hit With Failure-To-Warn Suit Over Cipro
- Novartis' Hemophilia Drug Patent Suit Stays In Texas
- FDA Warns Sun Over Oxycodone Quality Control Issues
- Most Admired Attys: Pepper Hamilton's Nina Gussack
- FDA Tells Baxter To Tone Down Aralast Claims
- Allergan Settles Botox Off-Label Claims For $600M
- GSK Paxil Suit Transferred From Minn. To NJ
- What To Know If A CEO Client Is Deposed